Management of metastatic renal cell carcinoma – mini review
<p>The management of metastatic renal cell carcinoma (mRCC) has evolved considerably in the last decade. A number of different systemic molecular targeted agents that have been recently approved have improved the survival of patients with mRCC. This mini-review focuses on the implementation of...
Main Authors: | Anubha Bharthuar, Himanshu Pandey, Swapan Sood |
---|---|
Format: | Article |
Language: | English |
Published: |
Codon Publications
2015-05-01
|
Series: | Journal of Kidney Cancer and VHL |
Subjects: | |
Online Access: | http://jkcvhl.com/index.php/jkcvhl/article/view/28 |
Similar Items
-
Practical updates in medical therapy for advanced and metastatic renal cell carcinoma
by: Ning Yi Yap, et al.
Published: (2018-01-01) -
PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH CHEMOTHERAPY
by: Deyan Davidov
Published: (2016-03-01) -
Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy
by: Yan Song, et al.
Published: (2016-01-01) -
Metastatic renal cell carcinoma: Current scenario and future trends
by: Anubha Bharthuar
Published: (2012-07-01) -
SEQUENTIAL USE OF TARGET AGENTS AND THEIR COMBINATION IN THE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA
by: B. Ya. Alekseyev, et al.
Published: (2014-08-01)